FDA says Novartis knew its application for $2.1 million gene therapy included errors https://t.co/EdeB9unC3t

— ??”MAGA MAN”?? (@GhostTrumps) August 6, 2019

https://t.co/qDztBtQg2H
Just a few weeks after approval, the most expensive drug in the word is questionned by the FDA In the near future crosschecking & data control will make cheating rather impossible. @dr_wardsam @numerikare @DigitalHealthBE @B_Hf_T

— Karolien Haese (@Karolien1231) August 6, 2019

...well this hurts more than $NVS....https://t.co/HQAUlGFSuO

— Cole T.F. Roberts (@ColeTFR) August 6, 2019

#Novartis caught manipulating study data to get "the most expensive drug in the world" approved https://t.co/nGey1LAwoV

— HighWire (@HighWireTalk) August 6, 2019

FDA: Novartis knew of manipulation of data supporting Zolgensma approval by ⁦@adamfeuerstein⁩ https://t.co/08p79TkGzV

— Matthew Herper (@matthewherper) August 6, 2019

Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/FkJD9sc6jP $NVS

— Adam Feuerstein (@adamfeuerstein) August 6, 2019

BREAKING: Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/nEDtHPiT2C

— STAT (@statnews) August 6, 2019

?

Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/JC0eEEMvtm via @statnews

— Sek Kathiresan MD (@skathire) August 6, 2019

Remember the world’s most expensive drug in history receiving FDA approval in May 2019? $2.1M for a SINGLE infusion. Lots more to story: Novartis manipulated data in its application & delayed telling FDA until AFTER it was approved ▶️https://t.co/MXoATr35EV#BigPharma #cdnhealth https://t.co/6Jo9QAgoLs

— Kulvinder Kaur MD (@dockaurG) August 7, 2019

Novartis concealed its manipulated data from the FDA while applying for approval of its extremely expensive gene therapy treatment.

https://t.co/BlwvXD9mAO

— Carl Elliott (@FearLoathingBTX) August 6, 2019

"The drug maker Novartis concealed manipulated data from the Food and Drug Administration while applying for approval of an extremely expensive gene therapy treatment and then delayed reporting the issue, the agency said on Tuesday." https://t.co/m2n1TgGmsD By @katie_thomas

— Leigh Turner (@LeighGTurner) August 6, 2019

"Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment" by KATIE THOMAS via NYT https://t.co/EtymcOJc8Q

— Scott McKibbin (@McKibbinGroup) August 6, 2019

Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment https://t.co/IwMDyCxOni

— (((Jody Ranck))) (@jranck) August 6, 2019

I am sad to say, I'm nearly 100% confident this is not only example of manipulation of data submitted to the FDA.

Only fix is to mandate trial data sharing.@jamesheathers @RetractionWatch@thebyrdlab @rwyeh @bnallamo @VPrasadMDMPH @hmkyalehttps://t.co/TIid7T3SEq

— Venk Murthy (@venkmurthy) August 7, 2019

This is absolutely horrendous. But it’s worth noting how much these proven real-world BigPharma conspiracies fall from the hiding-the-cure-for-cancer-and-keeping-ppl-sick-for-profit-level where the internet conspiracy theories are at https://t.co/vRmaRyeI29

— Pauli Ohukainen (@POhukainen) August 7, 2019

Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/0MOdXssmD0 via @statnews

— Gideon Gil (@GideonGil) August 6, 2019

Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/VlUJe0pdqB via @statnews

— Ben Hirschler (@reutersBenHir) August 7, 2019

When Zolgensma arrived on the market with the highest price ever seen, most pharma policy experts took for granted that this expensive drug stood on solid data. We were wrong.
Novartis was aware of manipulation of data supporting Zolgensma approval https://t.co/QpjDD9d4b1

— Marc-André Gagnon (@MA_Gagnon) August 6, 2019

More #bigpharma wrongdoing, this time manipulating data which may lead to “civil or criminal penalties”.

No product made by any of the criminal pharma companies should ever be mandated!#InformedConsent #SB276 #CAleg #Novartis #FDA #HearThisWellhttps://t.co/dM5e89yvWO

— Judea Johnson (@judeajohnson) August 6, 2019

Is @Novartis faking their data to a $2M/sale product? Nice. Can we have more (enforced) openness of commercial "research" please? https://t.co/tMm956zbCc

— KordingLab (@KordingLab) August 7, 2019

Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment https://t.co/Sn6L9d2ia1

— Heikki Saxén (@heikki_saxen) August 7, 2019

Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment - The New York Times https://t.co/v87J7x0nsc

— XENIA KOUNALAKI (@xkounalaki) August 7, 2019

BREAKING NEWS: The US FDA said that data manipulation took place during the pre-clinical trial of Zolgensma, a recently approved gene therapy for children with spinal muscular atrophy, a rare and often fatal genetic disease. https://t.co/y2X4nrHd7H#genetherapy #SMA @AveXisInc pic.twitter.com/f4fm7eGuJ3

— Precision Medicine World Conference (@PMWCintl) August 7, 2019

Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment https://t.co/RPIqoAJo0v

— D.K.R. Boyd (@ReflectingMan) August 7, 2019

Gene&Cell Therapy >> Published by Precision Medicine World Conference in Twitter: BREAKING NEWS: The US FDA said that data manipulation took… https://t.co/2Lv2JDoQF8 #LucidQuest #followthepatient #genetherapy #celltherapy #immunotherapy #biotech #cancer #regenerativemedicine pic.twitter.com/hUH2HbST67

— Dr Timos Papagatsias (@_timos_) August 7, 2019